These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8824364)
41. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Carter HB; Pearson JD; Metter EJ; Chan DW; Andres R; Fozard JL; Rosner W; Walsh PC Prostate; 1995 Jul; 27(1):25-31. PubMed ID: 7541528 [TBL] [Abstract][Full Text] [Related]
42. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men. Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591 [TBL] [Abstract][Full Text] [Related]
43. Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort. Park SY; Wilkens LR; Morris JS; Henderson BE; Kolonel LN Prostate; 2013 Feb; 73(3):261-6. PubMed ID: 22851289 [TBL] [Abstract][Full Text] [Related]
44. The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer. Loughlin KR Urol Oncol; 2016 Nov; 34(11):482.e1-482.e4. PubMed ID: 27423822 [TBL] [Abstract][Full Text] [Related]
45. Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Kehinde EO; Akanji AO; Memon A; Bashir AA; Daar AS; Al-Awadi KA; Fatinikun T Int Urol Nephrol; 2006; 38(1):33-44. PubMed ID: 16502050 [TBL] [Abstract][Full Text] [Related]
46. Alterations in androgen conjugate levels in women and men with alopecia. Legro RS; Carmina E; Stanczyk FZ; Gentzschein E; Lobo RA Fertil Steril; 1994 Oct; 62(4):744-50. PubMed ID: 7926083 [TBL] [Abstract][Full Text] [Related]
47. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. Gray A; Feldman HA; McKinlay JB; Longcope C J Clin Endocrinol Metab; 1991 Nov; 73(5):1016-25. PubMed ID: 1719016 [TBL] [Abstract][Full Text] [Related]
48. [The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer]. Knönagel H; Hauri D Helv Chir Acta; 1989 Aug; 56(3):347-50. PubMed ID: 2807964 [TBL] [Abstract][Full Text] [Related]
49. Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. Fears TR; Ziegler RG; Donaldson JL; Falk RT; Hoover RN; Stanczyk FZ; Vaught JB; Gail MH Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):785-9. PubMed ID: 12163335 [TBL] [Abstract][Full Text] [Related]
50. Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Hautanen A; Mänttäri M; Manninen V; Tenkanen L; Huttunen JK; Frick MH; Adlercreutz H Atherosclerosis; 1994 Feb; 105(2):191-200. PubMed ID: 8003095 [TBL] [Abstract][Full Text] [Related]
51. Sex hormones and the risk of incident prostate cancer. Daniels NA; Nielson CM; Hoffman AR; Bauer DC; Urology; 2010 Nov; 76(5):1034-40. PubMed ID: 20451981 [TBL] [Abstract][Full Text] [Related]
52. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. Lookingbill DP; Demers LM; Wang C; Leung A; Rittmaster RS; Santen RJ J Clin Endocrinol Metab; 1991 Jun; 72(6):1242-8. PubMed ID: 1827450 [TBL] [Abstract][Full Text] [Related]
54. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Eaton NE; Reeves GK; Appleby PN; Key TJ Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098 [TBL] [Abstract][Full Text] [Related]
55. Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. Allen NE; Reichardt JK; Nguyen H; Key TJ Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):578-81. PubMed ID: 12815006 [TBL] [Abstract][Full Text] [Related]
56. Androstanediol glucuronide in patients with pancreatic cancer and in those with chronic pancreatitis. Jansa R; Prezelj J; Kocijancic A; Osredkar J; Ferlic F Horm Metab Res; 1996 Aug; 28(8):381-3. PubMed ID: 8886824 [TBL] [Abstract][Full Text] [Related]
57. The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels. Severi G; Hayes VM; Tesoriero AA; Southey MC; Hoang HN; Padilla EJ; Morris HA; English DR; Sutherland RL; Boyle P; Hopper JL; Giles GG BJU Int; 2008 Feb; 101(4):492-6. PubMed ID: 17986287 [TBL] [Abstract][Full Text] [Related]
58. Influence of radical prostatectomy on serum hormone levels. Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896 [TBL] [Abstract][Full Text] [Related]